A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment

BACKGROUND: Nausea/vomiting (N/V) not related to anti-cancer treatment is common in patients with advanced cancer. The standard approach to management is to define a dominant cause, and treat with an antiemetic selected through pathophysiologic knowledge of emetic pathways. High rates of N/V control...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Hardy, Janet, Skerman, Helen, Glare, Paul, Philip, Jennifer, Hudson, Peter, Mitchell, Geoffrey, Martin, Peter, Spruyt, Odette, Currow, David, Yates, Patsy
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5932901/
https://ncbi.nlm.nih.gov/pubmed/29720113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4404-8
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi